Selwyn Ho is an experienced biopharma and biotech executive with nearly 30 years of experience across commercialization, drug development, and pre.
Selwyn Ho is an experienced biopharma and biotech executive with nearly 30 years of experience across commercialization, drug development, and pre- and post-product launches. His focus areas include ophthalmology, immunology, and immuno-oncology, leveraging cell therapy, monoclonal antibodies, and multi-specific antibody modalities. He currently serves as CEO of Medigene AG and has been appointed CEO of Signadori Bio.
Full founder directory · Investor directory · Company funding database · Fundraising library